Blog
Keep up to date with the latest news from Instem.
Challenges and Best Practices of Open-Source Solutions for Clinical Use
Read this blog to learn about the challenges and best practices when using open-source solutions in clinical trial data analytics.
The Journey of a Molecule – Preclinical Efficacy
Enhancing Study Quality and Data Integrity in the Preclinical Phase
INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031
Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA).
Implementing R in Modern Life Sciences: Managing Risk and Ensuring Compliance
In this blog, we answer a number of recurring questions about validation, reproducibility, governance, and risk while using R for clinical data analytics.
The Journey of a Molecule – Lead Optimization
Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization
The Case for Outsourcing EU CTR, Policy 0070 & HC Submissions
In this blog, we discuss the need to outsource CTT work for EU CTR, Policy 0070 & HC Submissions as pharma cuts back on internal CTT teams.
The Journey of a Molecule – Discovery
Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.
The Journey of a Molecule – Target Identification
With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.
Instem Announces Major UK Headquarters Refurbishment
Modernised Headquarters Underscores Instem’s Commitment to Innovation, Customer Excellence and the Local Region
